Brammer Bio, LLC, a leading player in the biopharmaceutical industry, is headquartered in the United States, with significant operational regions across North America and Europe. Founded in 2018, the company has quickly established itself as a trusted partner in the development and manufacturing of advanced therapies, particularly in the field of gene and cell therapy.
Brammer Bio offers a unique suite of services, including viral vector manufacturing and process development, tailored to meet the specific needs of its clients. The company’s commitment to quality and innovation has positioned it as a key contributor to the rapidly evolving landscape of biotherapeutics. With a focus on accelerating the delivery of life-changing therapies, Brammer Bio continues to achieve notable milestones, solidifying its reputation as a leader in the contract development and manufacturing organisation (CDMO) sector.
+40 vs industry average
Brammer Bio, LLC’s score of 70 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Brammer Bio, LLC?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has below-average carbon intensity
Industry performance
The Research Services industry has reduced its overall emissions by 19% since 2018
Reported emissions
No reported emissions data is available for Brammer Bio, LLC yet.
Brammer Bio, LLC's reported carbon emissions
Brammer Bio, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Thermo Fisher Scientific Inc., which influences its climate commitments and emissions reporting.
As part of its corporate family, Brammer Bio inherits climate initiatives and targets from Thermo Fisher Scientific Inc. This includes commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks. However, specific reduction targets or achievements for Brammer Bio itself have not been disclosed.
Brammer Bio's climate strategy is aligned with its parent company's broader sustainability goals, which focus on reducing greenhouse gas emissions across all scopes. The absence of direct emissions data suggests that the company is in the process of developing its own specific targets and initiatives, potentially cascading from Thermo Fisher's established practices.
In summary, while Brammer Bio, LLC does not currently report specific emissions figures, it is positioned within a corporate structure that prioritises climate action and sustainability, guided by the initiatives of Thermo Fisher Scientific Inc.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Brammer Bio, LLC’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Brammer Bio, LLC yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Brammer Bio, LLC yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project